Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis.
Rodríguez Portal JA, Brito García N, Díaz Del Campo Fontecha P, Valenzuela C, Ortiz AM, Nieto MA, Mena-Vázquez N, Cano-Jiménez E, Castellví I, Aburto M, Bonilla G, Hernández Hernández MV, Francisco Hernández FM, Correyero Plaza M, Castrejón I, Abad Hernández MÁ, Narváez J. Rodríguez Portal JA, et al. Among authors: aburto m. Reumatol Clin (Engl Ed). 2022 Oct;18(8):443-452. doi: 10.1016/j.reumae.2022.02.004. Epub 2022 Sep 6. Reumatol Clin (Engl Ed). 2022. PMID: 36085196 Free article.
Importance of early diagnosis and treatment in idiopathic pulmonary fibrosis.
Molina-Molina M, Aburto M, Acosta O, Ancochea J, Rodríguez-Portal JA, Sauleda J, Lines C, Xaubet A. Molina-Molina M, et al. Among authors: aburto m. Expert Rev Respir Med. 2018 Jul;12(7):537-539. doi: 10.1080/17476348.2018.1472580. Epub 2018 May 7. Expert Rev Respir Med. 2018. PMID: 29718749 Free article. No abstract available.
Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity.
Bermudo G, Suarez-Cuartin G, Rivera-Ortega P, Rodriguez-Portal JA, Sauleda J, Nuñez B, Castillo D, Aburto M, Portillo K, Balcells E, Badenes-Bonet D, Valenzuela C, Fernandez-Fabrellas E, González-Budiño T, Cano E, Acosta O, Leiro-Fernández V, Romero A, Planas-Cerezales L, Villar A, Moreno A, Laporta R, Vicens-Zygmunt V, Shull J, Franquet T, Luburich P, Molina-Molina M. Bermudo G, et al. Among authors: aburto m. Arch Bronconeumol. 2022 Feb;58(2):135-141. doi: 10.1016/j.arbres.2021.03.018. Epub 2021 Mar 27. Arch Bronconeumol. 2022. PMID: 33895005 Free article. English, Spanish.
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology.
Narváez J, Aburto M, Seoane-Mato D, Bonilla G, Acosta O, Candelas G, Cano-Jiménez E, Castellví I, González-Ruiz JM, Corominas H, López-Muñiz B, Martín-López M, Robles-Pérez A, Mena-Vázquez N, Rodríguez-Portal JA, Ortiz AM, Sabater-Abad C, Castrejón I, Dos Santos R, Garrote-Corral S, Maese J, Silva-Fernández L, Castañeda S, Valenzuela C. Narváez J, et al. Among authors: aburto m. Reumatol Clin (Engl Ed). 2023 Feb;19(2):74-81. doi: 10.1016/j.reumae.2021.12.003. Epub 2022 Jun 23. Reumatol Clin (Engl Ed). 2023. PMID: 35753951 Free article.
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment.
Narváez J, Díaz Del Campo Fontecha P, Brito García N, Bonilla G, Aburto M, Castellví I, Cano-Jiménez E, Mena-Vázquez N, Nieto MA, Ortiz AM, Valenzuela C, Abad Hernández MÁ, Castrejón I, Correyero Plaza M, Francisco Hernández FM, Hernández Hernández MV, Rodríquez Portal JA. Narváez J, et al. Among authors: aburto m. Reumatol Clin (Engl Ed). 2022 Nov;18(9):501-512. doi: 10.1016/j.reumae.2022.03.004. Epub 2022 Sep 3. Reumatol Clin (Engl Ed). 2022. PMID: 36064885 Free article.
Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study.
Martínez-Besteiro E, Molina-Molina M, Gaeta AM, Aburto M, Casanova Á, Rigual Bobillo J, Orozco S, Pérez Rojo R, Godoy R, López-Muñiz Ballesteros B, Pinillos Robles EJ, Sánchez Fraga S, Peña Miguel T, Balcells E, Laporta R, Rodríguez Portal JA, Herrera Lara S, Cabrera E, Acosta O, Peláez A, Valenzuela C. Martínez-Besteiro E, et al. Among authors: aburto m. Arch Bronconeumol. 2023 Apr;59(4):273-276. doi: 10.1016/j.arbres.2023.01.001. Epub 2023 Jan 6. Arch Bronconeumol. 2023. PMID: 36732159 Free PMC article. No abstract available.
[Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery].
Aburto M, Rodríguez-Portal JA, Fernandez-Fabrellas E, García Sevila R, Herrera Lara S, Bollo de Miguel E, González Ruiz JM, Molina-Molina M, Safont Muñoz B, Godoy Mayoral R, Romero Ortiz AD, Soler Sempere MJ, Castillo Villegas D, Gaudó Navarro J, Tomás López L, Nuñez Sanchez B, Palacios Hidalgo Z, Sellares Torres J, Sacristán Bou L, Nieto Barbero MA, Casanova Espinosa A, Portillo-Carroz K, Cano-Jimenez E, Acosta Fernández O, Legarreta MJ, Valenzuela C; en representación del Grupo SEPAR-IPF National Registry. Aburto M, et al. Open Respir Arch. 2024 May 15;6(3):100334. doi: 10.1016/j.opresp.2024.100334. eCollection 2024 Jul-Sep. Open Respir Arch. 2024. PMID: 39021619 Free PMC article. Spanish.
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.
69 results